Cargando...

Successful response to first-line treatment with osimertinib for choroidal metastasis from EGFR-mutated non-small-cell lung cancer

Purpose: Describe the use of osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, as the first-line treatment in a patient with choroidal and central nervous system metastases from EGFR-mutated non-small cell lung cancer. Observations: A 68-year-old man...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Matthew G. Field, H. Culver Boldt, Taher Abu Hejleh, Elaine M. Binkley
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2022-06-01
Colección:American Journal of Ophthalmology Case Reports
Materias:
Acceso en línea:http://www.sciencedirect.com/science/article/pii/S2451993622002055
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!